Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -33.97% is in line with its 5-year average of -32.78%, around the middle of its 5-year range (-70.02%–19.04%).
As of the fiscal period ended Tuesday, June 30, 2026. 57.14% below its 12-month average of -21.62%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -33.97%.
RETURN ON EQUITY (ROE)
-33.97%
RETURN ON EQUITY (ROE) AVG TTM
-21.62%
RETURN ON EQUITY (ROE) AVG 3Y
-41.23%
RETURN ON EQUITY (ROE) AVG 5Y
-32.78%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-57.14%
CURRENT VS 3Y AVG
+17.61%
CURRENT VS 5Y AVG
-3.63%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+19.14%
vs the sector median at left
Sol-Gel Technologies Ltd.
Market Cap
$244.50M
Return on Equity (ROE)
-33.97%
TTM Avg
-21.62%
3Y Avg
-41.23%
5Y Avg
-32.78%
Market Cap
$243.55M
Return on Equity (ROE)
-47.25%
TTM Avg
-42.23%
3Y Avg
-50.43%
5Y Avg
-29.25%
Market Cap
$246.22M
Return on Equity (ROE)
N/A
TTM Avg
35.05%
3Y Avg
64.68%
5Y Avg
-167.54%
Market Cap
$242.28M
Return on Equity (ROE)
31.90%
TTM Avg
-385.06%
3Y Avg
-191.20%
5Y Avg
-142.10%
Market Cap
$241.94M
Return on Equity (ROE)
N/A
TTM Avg
-1340.59%
3Y Avg
-55.32%
5Y Avg
-61.68%
Market Cap
$237.16M
Return on Equity (ROE)
-59.27%
TTM Avg
-136.66%
3Y Avg
-113.26%
5Y Avg
-53.68%
Market Cap
$238.57M
Return on Equity (ROE)
-31.55%
TTM Avg
-30.05%
3Y Avg
-33.97%
5Y Avg
-37.95%
Market Cap
$244.74M
Return on Equity (ROE)
N/A
TTM Avg
-125.28%
3Y Avg
-42.20%
5Y Avg
-43.41%
Market Cap
$251.38M
Return on Equity (ROE)
-57.76%
TTM Avg
-27.79%
3Y Avg
-4.11%
5Y Avg
-4.11%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sol-Gel Technologies Ltd. (SLGL) | $244.50M | -33.97% | -21.62% | -41.23% | -32.78% |
| Century Therapeutics, Inc. (IPSC)vs › | $243.55M | -47.25% | -42.23% | -50.43% | -29.25% |
| Galectin Therapeutics Inc. (GALT)vs › | $246.22M | N/A | 35.05% | 64.68% | -167.54% |
| Q32 Bio Inc. (QTTB)vs › | $242.28M | 31.90% | -385.06% | -191.20% | -142.10% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | N/A | -1340.59% | -55.32% | -61.68% |
| Invivyd, Inc. (IVVD)vs › | $237.16M | -59.27% | -136.66% | -113.26% | -53.68% |
| High Tide Inc. (HITI)vs › | $238.57M | -31.55% | -30.05% | -33.97% | -37.95% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $244.74M | N/A | -125.28% | -42.20% | -43.41% |
| Upstream Bio, Inc. (UPB)vs › | $251.38M | -57.76% | -27.79% | -4.11% | -4.11% |
| SIGA Technologies, Inc. (SIGA)vs › | $237.41M | -1.67% | 19.58% | 23.42% | 29.49% |
ROE
-34.0%
ROA
-30.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -33.97% |
| 2026-03-31 | -2.03% |
| 2025-12-31 | -26.86% |
| 2025-09-30 | -34.52% |
| 2025-06-30 | -10.70% |
| 2025-03-31 | -64.66% |
| 2024-12-31 | -36.67% |
| 2024-09-30 | -27.58% |
| 2024-06-30 | -42.73% |
| 2024-03-31 | -70.02% |
| 2023-12-31 | -69.30% |
| 2023-09-30 | -64.30% |
| 2023-06-30 | -52.64% |
| 2023-03-31 | -44.46% |
| 2022-12-31 | -35.35% |
| 2022-09-30 | 10.31% |
| 2022-06-30 | 19.04% |
| 2022-03-31 | 3.37% |
| 2021-12-31 | 5.79% |
| 2021-09-30 | -41.74% |
| 2021-06-30 | -69.31% |
| 2021-03-31 | -55.76% |
| 2020-12-31 | -57.60% |
| 2020-09-30 | -51.44% |
| 2020-06-30 | -42.94% |
| 2020-03-31 | -38.72% |
| 2019-12-31 | -46.91% |
| 2019-09-30 | -51.02% |
| 2019-06-30 | -55.24% |
| 2019-03-31 | -54.63% |
| 2018-12-31 | -50.39% |
| 2018-09-30 | -34.41% |
| 2018-06-30 | -39.68% |
| 2018-03-31 | -36.36% |
